Among the various mechanisms involved in the immunological escape of tumor cells, activated immune checkpoint pathways, including the PD-1/PD-L1 and CTLA-4 axis, are the central suppressors amenable to therapeutic inhibition (Figure 1, left). The gene discussed is CTLA4; the disease is neoplasm.